Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 17411-17412 [2013-06438]

Download as PDF Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices disabilities areas, as well as discuss health equity recommendations to the CDC ACD. The agenda is subject to change as priorities dictate. Contact Person for More Information: Leandris Liburd, Ph.D., M.P.H., M.A., Designated Federal Officer, Health Disparities Subcommittee, Advisory Committee to the Director, CDC, 1600 Clifton Road NE., M/S K–77, Atlanta, Georgia 30333 Telephone (770) 488–8200, Email: LEL1@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Officer, OID, CDC, 1600 Clifton Road NE., Mailstop D10, Atlanta, Georgia 30333, Telephone: (404) 639–4461. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC). DEPARTMENT OF HEALTH AND HUMAN SERVICES Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–06433 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention [FR Doc. 2013–06431 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P Board of Scientific Counselors, National Center for Health Statistics DEPARTMENT OF HEALTH AND HUMAN SERVICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following meeting of the aforementioned committee: Centers for Disease Control and Prevention Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID) emcdonald on DSK67QTVN1PROD with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned committee: Time and Date: 2:00 p.m.–3:00 p.m., April 18, 2013. Place: Teleconference. Status: The meeting is open to the public; the toll free dial in number is 1–877–951– 7311 with a pass code of 6420598. Purpose: The BSC, OID, provides advice and guidance to the Secretary, Department of Health and Human Services; the Director, CDC; the Director, OID; and the Directors of the National Center for Immunization and Respiratory Diseases, the National Center for Emerging and Zoonotic Infectious Diseases, and the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, in the following areas: strategies, goals, and priorities for programs; research within the national centers; and overall strategic direction and focus of OID and the national centers. Matters To Be Discussed: The purpose of the meeting is to discuss the potential for forming an infectious disease laboratory working group under the BSC, OID. The agenda and any supplemental material will be available at www.cdc.gov/oid/ BSC.html after April 1. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robin Moseley, M.A.T., Designated Federal VerDate Mar<14>2013 15:09 Mar 20, 2013 Jkt 229001 Times and Dates: 11:00 a.m.–5:30 p.m., May 6, 2013, 8:30 a.m.–1:00 p.m., May 7, 2013 Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. Status: This meeting is open to the public; however, visitors must be processed in accordance with established federal policies and procedures. For foreign nationals or nonUS citizens, pre-approval is required (please contact Althelia Harris, 301–458–4261, adw1@cdc.gov or Virginia Cain, vcain@cdc.gov at least 10 days in advance for requirements). All visitors are required to present a valid form of picture identification issued by a state, federal or international government. As required by the Federal Property Management Regulations, Title 41, Code of Federal Regulation, Subpart 101– 20.301, all persons entering in or on Federal controlled property and their packages, briefcases, and other containers in their immediate possession are subject to being xrayed and inspected. Federal law prohibits the knowing possession or the causing to be present of firearms, explosives and other dangerous weapons and illegal substances. The meeting room accommodates approximately 100 people. Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters To Be Discussed: The agenda will include welcome remarks by the Acting PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 17411 Director, NCHS; the February 5, 2013 ORM Program Review; discussion of revisions to the program review protocol; program updates. Requests to make oral presentations should be submitted in writing to the contact person listed below. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by April 22, 2013. The agenda items are subject to change as priorities dictate. Contact Person for More Information: Virginia S. Cain, Ph.D., Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7208, Hyattsville, Maryland 20782, telephone (301) 458–4500, fax (301) 458–4020. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–06432 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review The meeting announced below concerns Monitoring and Evaluation of Malaria Control and Elimination Activities, FOA GH13–005, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 11:00 a.m.–3:00 p.m., May 21, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Monitoring and Evaluation of Malaria Control and Elimination Activities, FOA GH13–005, initial review.’’ Contact Person for More Information: Hylan D. Shoob, Ph.D., M.S.P.H., Scientific E:\FR\FM\21MRN1.SGM 21MRN1 17412 Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices Review Officer, CDC, 1600 Clifton Road NE., Mailstop D–72, Atlanta, Georgia 30333, Telephone: (404) 639–4796. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review emcdonald on DSK67QTVN1PROD with NOTICES The meeting announced below concerns Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa, FOA GH13– 002, initial review. In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Time and Date: 1:00 p.m.–4:30 p.m., May 23, 2013 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa, FOA GH13–002, initial review.’’ Contact Person for More Information: Diana Bartlett, Scientific Review Officer, Office of the Associate Director for Science, Office of Science Quality, CDC, 1600 Clifton Road NE., Mailstop D–72, Atlanta, Georgia 30033, Telephone (404) 639–4938, zxd5@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Jkt 229001 Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Medicare & Medicaid Services [Document Identifier CMS–R–218] [FR Doc. 2013–06437 Filed 3–20–13; 8:45 am] Agency Information Collection Activities: Submission for OMB Review; Comment Request BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Funding Opportunity Announcement, Initial Review BILLING CODE 4163–18–P 15:09 Mar 20, 2013 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [FR Doc. 2013–06438 Filed 3–20–13; 8:45 am] VerDate Mar<14>2013 Prevention and the Agency for Toxic Substances and Disease Registry. The meeting announced below concerns Indoor Environment of LowIncome Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001, initial review. SUMMARY: This document corrects a notice that was published in the Federal Register on February 28, 2013 (78 FR 13677). The meeting announcement and matters to be discussed should read as follows: The meeting announced below concerns Indoor Environment of LowIncome Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001, initial review. Matters To Be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Indoor Environment of Low-Income Renovated Multifamily Housing in the Western Region of the United States (U01), FOA EH13–001’’. FOR FURTHER INFORMATION CONTACT: J. Felix Rogers, Ph.D., M.P.H., Scientific Review Officer, CDC, 4770 Buford Highway NE., Mailstop F63, Atlanta, Georgia 30341, Telephone: (770) 488– 4334. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–06434 Filed 3–20–13; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS) is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Reinstatement of a previously approved collection; Title of Information Collection: Health Insurance Portability and Accountability Act (HIPAA) Standards for Electronic Transactions and Supporting Regulations in 45 CFR Part 162. Use: This information collection request has no substantive changes since the last OMB approval in 2008. The adopted transaction standards currently in use for electronic transactions (Version 4010/4010a) are compatible with the ICD–9–CM adopted code set that is used to report diagnoses and hospital inpatient services. However, the ICD–10 codes cannot be used with Version 4010/4010a, because this version does not have a specific qualifier or indicator for reporting ICD– 10 codes. Version 5010 supports the use of the ICD–10 code set by making available a qualifier to indicate that an ICD–10 code is being reported. Like ICD–9, ICD–10 codes are reported in claim and payment transactions, as well as eligibility inquiries and responses and requests for referrals and authorizations. In Version 5010, the number of codes required in any given transaction does not change. It is possible that a fewer AGENCY: E:\FR\FM\21MRN1.SGM 21MRN1

Agencies

[Federal Register Volume 78, Number 55 (Thursday, March 21, 2013)]
[Notices]
[Pages 17411-17412]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-06438]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Monitoring and Evaluation of 
Malaria Control and Elimination Activities, FOA GH13-005, initial 
review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Time and Date: 11:00 a.m.-3:00 p.m., May 21, 2013 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Monitoring and Evaluation of Malaria Control and 
Elimination Activities, FOA GH13-005, initial review.''
    Contact Person for More Information: Hylan D. Shoob, Ph.D., 
M.S.P.H., Scientific

[[Page 17412]]

Review Officer, CDC, 1600 Clifton Road NE., Mailstop D-72, Atlanta, 
Georgia 30333, Telephone: (404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Dana Redford,
Acting Director, Management Analysis and Services Office Centers for 
Disease Control and Prevention.
[FR Doc. 2013-06438 Filed 3-20-13; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.